News updates: nano-based vaccines and therapeutics for treatment of COVID-19

Written by Ilana Landau and Lucy Chard

COVID-19 vaccine trials and updates

A timeline of responses from researchers, biotechnology companies and funding bodies in a global effort to develop, test and distribute vaccines and therapeutics for COVID-19 as quickly and safely as possible.   FDA authorizes emergency use of Moderna‚Äôs COVID-19 vaccine candidate in USA Moderna (MA, USA) has announced that the US FDA has authorized the emergency use of its mRNA COVID-19 vaccine candidate, mRNA-1273, in individuals aged 18 years and older. The company intends to file a Biologics License Application with the FDA for full US licensure in 2021 and continues to gather additional data regarding the vaccine. To read...

To view this content, please register now for access

It's completely free